Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
07 December, 2021 20:48 IST
Ipca Laboratories board approves acquisition of 26% stake in Lyka Labs
Source: IRIS | 24 Nov, 2021, 05.09PM
Rating: NAN / 5 stars.
Comments  |  Post Comment


Ipca Laboratories, a Mumbai-based drug-maker, announced that the board has approved acquisition of 26.574% of the paid-up share capital of Lyka Labs and has entered into a Joint Management Control Agreement with the Promoters of Lyka Labs. The cost of acquisition is Rs 978.9 million.

Consequent to this acquisition of shares, the Company has also made a public announcement to acquire 26% additional equity shares of the said company from its public shareholders under the SEBI (SAST) Regulations, 2011.

Shares of the company gained Rs 24.55, or 1.19%, to settle  at  Rs 2,082.25  The total volume of shares traded  was 14,650 at  the BSE (Wednesday).




 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Hero Motocorp expands operations in Argentina - 07-Dec-2021 17:13
Biocon partners with Tabuk Pharmaceuticals - 07-Dec-2021 13:38
Onward Technologies acquires NV Pune Technology Park - 06-Dec-2021 19:24
Lupin enters into pact with Biomm - 06-Dec-2021 19:12
ICICI Bank: Growing franchise through technological innovations - 06-Dec-2021 13:28
Godrej Properties to develop luxury residential project in Delhi - 06-Dec-2021 13:13
Ramkrishna Forgings wins domestic order worth Rs 720 mn - 06-Dec-2021 12:58
L&T inks pact with Kemroc to distribute cutting-edge products in India - 03-Dec-2021 17:07
Delta Corp's associate to invest in WSPL Containers - 03-Dec-2021 16:51
Morepen gets USFDA nod for Fexofinadine (Allegra) - 03-Dec-2021 16:25
Motilal Oswal recommends Buy on TCI; target price of Rs 790 - 02-Dec-2021 13:08
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer